COT Meeting: 6th February 2024
On this page
Skip the menu of subheadings on this page.Meeting Agenda
1. Apologies for absence
2. Draft minutes and reserved minutes of the 12th December 2023 meeting TOX/MIN/2023/07.
3. Matters arising.
4. Second draft statement on the potential risks from ergot alkaloids in the maternal diet TOX/2024/01.
5. Third draft statement on the safety of Titanium Dioxide (E171) as a Food Additive TOX/2024/02.
6. Benchmark dose modelling in a UK chemical risk assessment framework TOX/2024/03.
7. Advancing in silico methods for chemical risk assessment – update from the FSA fellow TOX/2024/04.
8. Draft 2022 COT Annual Report TOX/2024/05.
9. Annual COT Horizon Scanning TOX/2024/06.
10. Update on actions taken subsequent to the Committee’s advice TOX/2024/07.
11. Fourth draft interim position statement on bisphenol A TOX/2024/08.
12. Update on the work of other FSA Scientific Advisory Committees - for information TOX/2024/09.
13. Any other business.
Matters arising:
- Continuous Improvements - TOX/2024/10 - Reserved
- JEG updates.
- Folic acid and hypersensitivity.
Media discussed during the meeting
TOX/MIN/2023/07
Draft Minutes of the 12th December 2023 COT Meeting
TOX/2024/01
Second draft statement on the potential risks from ergot alkaloids in the maternal diet
TOX/2024/02
*Statement coming soon*
TOX/2024/03
Benchmark dose modelling in a UK chemical risk assessment framework
TOX/2024/04
Advancing in silico methods of assessing toxicological risk
TOX/2024/05
2023 Annual Report of the COT and Annex A
Annex B to 2023 Annual Report of the COT
2023 Draft Annual Report - for discussion
TOX/2024/06
Potential future discussion items – horizon scanning
TOX/2024/07
Update on actions taken subsequent to COT advice – Paper for information
TOX/2024/08
Fourth draft interim position paper on bisphenol A
TOX/2024/09
Update on the work of other Scientific Advisory Committees- February 2024